Launch of our HCV therapy. AbbVie is normally issuing diluted earnings-per-share assistance for the full-year 2014 of $3.00 to $3.10 on an modified basis, or $2.63 to $2.73 on a […]

Regional testicular factors or environmentally friendly or genetic background could be responsible for the phenotypic variability highlighted in previously reported instances. In particular, investigations of the Y haplotype in individuals […]

He remained clinically improved for 19 a few months of treatment but required resection of his vestibular schwannoma for tumor development. Four of five individuals reported subjective improvement in baseline […]

Today, the New York Times reports on a key rebate plan that Genentech is using to apparently encourage doctors to prescribe Lucentis for macular degeneration rather than the less pricey […]

Scleroderma occurs whenever a person’s immune system mistakenly episodes and destroys healthful body tissue. Previous research claim that systemic scleroderma is normally more prevalent, occurs at a youthful age group […]